Reference ranges for urinary levels of testosterone and epitestosterone, which may reveal gonadal function, in a Korean male population  by Moon, Ju-Yeon et al.
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Cannabis,  or  marijuana,  the most  commonly  used  illicit  drug  in the  world,  has  been  shown  to  be  respon-
sible  for  suppressing  the  production  and  secretion  of androgens,  particularly  testosterone.  However,
despite  such  ﬁndings  in animals,  the  chronic  effects  of  marijuana  use  on  human  endocrine  systems  have
proved  to be inconsistent.  Here,  we  investigated  the  reference  ranges  of  urinary  levels  of  testosterone
(T)  and  epitestosterone  (E)  as  well  as  their metabolic  ratio  of  T/E  in  a  Korean  male  population  (n = 337),eywords:
estosterone
pitestosterone
/E ratio
arijuana
orean
which  would  enable  an evaluation  of abnormal  changes  in  steroid  metabolism  induced  by  habitually
administered  cannabis.  The  T/E ratio  was  signiﬁcantly  decreased  in  the  marijuana  group  (n =  18),  while
the  urinary  testosterone  concentrations  were  also  tended  to decrease.  This  study  is the  ﬁrst  to  provide
data  for  the reference  values  of  two  urinary  androgens  and  T/E values  among  control  Korean  males,  and,
furthermore,  suggests  that  the T/E ratio,  though  not  testosterone  levels,  might  be used to understand  the
suppression  of human  male  gonadal  function  affected  by  smoking  marijuana.
© 2013 The Authors. Published by Elsevier Ltd. All rights reserved.. Introduction
Cannabis, or marijuana, is the most commonly used illicit
rug in the world. It contains at least 61 cannabinoids, of which
9-tetrahydrocannabinol (THC) is the primary psychoactive ingre-
ient [1]. Although THC-based drugs for the treatment of pain and
ausea are already FDA approved and prescribed, the endocrine
roperties of marijuana have only been investigated since the
970s [2]. The clinical impacts of marijuana on endocrine systems,
ncluding the gonadal, adrenal, prolactin, growth hormone, and
hyroid hormone systems, in experimental models have been
eported [3–5]. In particular, the chronic use of cannabinoids sig-
iﬁcantly suppresses the production and secretion of androgens,
Abbreviations: Min, minimum; IQ1, interquartile 1 (25% quartile); IQ3,
nterquartile 3 (75% quartile); Max, maximum.
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ons Attribution-NonCommercial-No Derivative Works License, which permits
on-commercial use, distribution, and reproduction in any medium, provided the
riginal author and source are credited.
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960-0760/$ – see front matter ©  2013 The Authors. Published by Elsevier Ltd. All rights 
ttp://dx.doi.org/10.1016/j.jsbmb.2013.12.001notably testosterone in vitro and in vivo [6–8]. However, there is
conﬂicting evidence that the use of cannabinoids in humans has
little effect on the metabolic fate of testosterone [3,5,9–11].
The urinary T/E ratio, i.e.,  the ratio of testosterone (T) to
epitestosterone (E; a naturally occurring 17-epimer of T), has
been used to determine exogenous administration or abnormally
high testosterone levels because the T/E value does not vary
within an individual and shows little inter-individual variation [12].
The interconversion between testosterone and epitestosterone in
humans is negligible. Further, the concentration of epitestosterone
is not affected by the intake of testosterone [13–15]. Therefore,
change in the urinary T/E ratio in humans is of great interest
in doping control because it is affected by various drugs and
nutritional supplements [16–18]. However, no metabolic associ-
ations between the T/E ratio and habitual marijuana use have been
reported to date.
The biological actions of testosterone in androgen-dependent
neoplasms and healthy conditions vary considerably across
racial/ethnic groups [19–21]. The T/E ratio in Caucasian athletes
shows a median value of 1.1, and was  5.6 or less in 99% of the male
athletes, whereas in Korean populations, the median value was 0.15
[22,23]. In the present study, we examined the urinary levels of
testosterone and epitestosterone, as well as T/E ratios, in Korean
reserved.
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ale marijuana abusers compared with those in drug-free con-
rols in an attempt to determine whether marijuana has an effect
n endogenous steroid metabolism.
. Experimental
.1. Materials
Reference standards of testosterone and epitestosterone were
btained from Sigma (St. Louis, MO,  USA). THC–COOH was pur-
hased from Cerilliant (Round Rock, TX, USA). The internal
tandards, d3-testosterone, d3-epitestosterone, and d9-11-nor-9-
arboxy-9-tetrahydrocannabinol (THC-COOH-d9), were obtained
rom C/D/N Isotopes (Pointe-Claire, Quebec, Canada) and Cerilliant.
odium acetate (reagent grade, anhydrous) and sodium phosphate
ibasic were also purchased from Sigma. For enzymatic hydroly-
is, a 50% glycerol solution of -glucuronidase from Escherichia coli
140 U/mL) was supplied by Roche (Mannheim, Germany) and
n Oasis HLB cartridge (3 mL,  60 mg)  for solid-phase extraction
SPE) was obtained from Waters (Milford, MA,  USA). The derivatiz-
ng agents N-methyl-N-triﬂuorotrimethylsilyl acetamide (MSTFA),
mmonium iodide (NH4I), and dithioerythritol (DTE) were pur-
hased from Sigma. All organic solvents were of HPLC grade and
upplied by J. T. Baker (Phillipsburg, NJ, USA). The water was puri-
ed using a Direct-Q water puriﬁcation system (Millipore, Bedford,
A,  USA).
.2. Subjects
Study subjects included two groups: 18 male marijuana users
ged from 24 to 57 years (mean 40.2 ± 9.9 years), and 337 drug-free
ale aged from 22 to 52 years (mean 30.3 ± 5.4 years) as the mar-
juana non-users. Urine samples of the marijuana user as habitual
rug offenders (>6 months) and non-user groups were collected
t the Narcotics Departments of the District Prosecutors’ Ofﬁces
Seoul, South Korea) and at the Doping Control Center (Seoul, South
orea), respectively. The study was approved by the Ethics Com-
ittee of the Forensic Science Planning Ofﬁce at the Supreme
rosecutors’ Ofﬁce, and informed consent (written or oral) was
btained from each participant before collecting the urine samples.
.3. Sample preparation
Sample preparations for quantiﬁcation of the T/E ratio and
HC–COOH were based on previous reports [24,25]. Brieﬂy, urine
amples (2 mL)  spiked with 20 L of two internal standards (d3-
estosterone and d3-epitestosterone; 1 g/mL) were extracted
ith Oasis HLBTM SPE cartridges coupled to a peristaltic pump.
fter loading a sample onto a cartridge, the cartridge was washed
ith 2 mL  water and eluted twice with 2 mL  of methanol. Combined
ethanol eluates were evaporated under a stream of nitrogen
nd then 1 mL  of 0.2 M acetate buffer (pH 7.2) and 50 L of -
lucuronidase were was added. After incubation at 55 ◦C for 1 h, the
olution was extracted twice with 2.5 mL  of ethylacetate:n-hexane
2:3, v/v). The combined organic solvent extracts were evaporated
sing an N2 evaporator at 40 ◦C and further dried in a vacuum des-
ccator over P2O5-KOH for at least 30 min. Finally, the dried residue
as derivatized with MSTFA/NH4I/DTE (40 L; 500:4:2, v/w/w) at
0 ◦C for 20 min  and 2 L of the resulting mixture was  subjected to
as chromatography–mass spectrometry (GC–MS) in selected-ion
onitoring (SIM) mode.
For THC–COOH quantiﬁcation, urine samples (2 mL)  were spikedith 20 L of internal standard (THC–COOH-d9; 1 g/mL) in 1 mL  of
hosphate buffer (0.2 M,  pH 7.2), and then incubated with 50 L of
-glucuronidase for 1 h at 55 ◦C. The Oasis HLB SPE cartridges were
laced in a device ﬁtted with a small peristaltic pump and each was& Molecular Biology 140 (2014) 100– 105 101
washed with 2 mL  water and eluted twice with 1.5 mL  of methanol.
The combined methanol eluates were evaporated under a stream
of nitrogen, and residues were further dried in a vacuum desiccator
over P2O5-KOH for 30 min. Dried extracts were trimethylsilylated
and then analyzed in the GC–SIM/MS.
2.4. Instrumental analysis
GC–MS analysis was  carried out using an Agilent 6890 Plus gas
chromatograph interfaced with a single-quadrupole Agilent 5975
MSD. The electron energy was 70 eV and the ion source temperature
was 230 ◦C. Each sample (2 L) was  injected in split mode (10:1) at
an injector temperature of 280 ◦C and separated by passing through
an Ultra-1 capillary column (25 m × 0.2 mm i.d., 0.33 m ﬁlm thick-
ness; Agilent Technologies, Palo Alto, CA). The oven temperature
was initially 215 ◦C, which was  ramped to 260 ◦C at 1 ◦C/min, and
then ﬁnally increased to 320 ◦C (held for 1 min) using a 15 ◦C/min
ramping program. Ultra-high purity helium was used as the car-
rier gas with a column head pressure of 210.3 kPa (column ﬂow:
1.0 mL/min at an oven temperature of 215 ◦C).
Urinary THC–COOH was chromatographed through an Ultra-2
capillary column (25 m × 0.2 mm I.D., 0.33 m ﬁlm thickness; Agilent
Technologies). Electron energy of 70 eV and ion source tempera-
ture of 230 ◦C were used. Each sample (2 L) was injected in split
mode (10:1) at 280 ◦C, using the following GC  conditions: initial
oven temperature of 200 ◦C, ramped to 240 ◦C at 8 ◦C/min, then to
310 ◦C at 10 ◦C/min, and then held for 5 min. Helium was used as
a carrier gas at a column head pressure of 173 kPa (column ﬂow:
0.8 ◦C/min at an oven temperature of 200 ◦C).
2.5. Statistical analysis
Data manipulation was performed using Sigmaplot (SYSTAT
Software Inc., San Jose, CA) and an SPSS (v. 21) for Windows (SPSS
Inc, Chicago, IL) software package. Statistical analysis was preceded
by the Shapiro–Wilk test for normality calculates the probability
that the sample was drawn from a normal population. According to
its normality, the concentrations of testosterone (T) and epitestos-
terone (E) and the T/E ratio in the urine samples obtained from
male marijuana users and control male subjects were compared
using a non-parametric Mann–Whitney U-test. Also, correlations
between variables were tested using a non-parametric Spearman’s
rho correlation coefﬁcient. P-values <0.05 were considered statis-
tically signiﬁcant.
Median, mean, standard deviation, minimum, maximum, and
quartiles were used as descriptive statistics for reference distribu-
tions. Outliers (Y) were identiﬁed according to Tukey’s rule based
on the following equations:
Y < (Q1 – 1.5IQR) or Y > (Q3 + 1.5IQR), where Q1 denotes the
lower quartile (the 25th percentile), Q3 denotes the upper quartile
(the 75th percentile), and IQR = (Q3 – Q1) denotes the interquartile
range [26].
3. Results
3.1. Reference levels of urinary testosterone and epitestosterone
in Korean males
In this study, 337 Korean drug-free male with a mean age of
30 years (range: 22 to 52 years) were investigated (Fig. 1A) to
determine healthy reference values of testosterone and epitestos-
terone, which could contribute to better understand the different
incidence of some androgen-dependent pathologies between eth-
nical groups. The mean, median, ﬁrst (IQ1) and third (IQ3) quartiles,
and minimum and maximum values for urinary testosterone and
epitestosterone concentrations and the T/E ratio are presented in
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Fig. 1. Frequency distribution of age (A) and urinary T/E ratio (B) in a healthy Korean male population. The number of frequency is shown along the y-axis with the age and
T/E  ratio shown on the x-axis. The number of subjects in the sample is 337, while the median values of age and T/E ratio are 30 yr and 1.287, respectively.
Table 1
Reference ranges for urinary concentrations and ratio of testosterone (T) and epitestosterone (E) in a control male Korean population (n = 337).
Parameters Min  IQ1 Median Mean IQ3 Max
Testosterone (T) 0.74 8.28 20.03 25.46 30.32 173.92
Epitestosterone (E) 0.12 7.34 15.45 21.70 30.35 99.46
T/E  ratio 0.116 0.683 1.342 1.693 2.509 7.583
Concentrations of T and E are expressed as ng/mL, and T/E ratio is presented as the ratio of testosterone/epitestosterone in each subject.
Table  2
Comparison of urinary concentrations and ratio of testosterone (T) and epitestosterone (E) between control subjects and marijuana users in a Korean male population.
Age (yr.) Control subjects Marijuana users P-value
n T (ng/mL) E (ng/mL) T/E ratio n T (ng/mL) E (ng/mL) T/E ratio T E T/E
20–29 178 22.3 (17.3–40.8) 19.2 (9.3–34.7) 1.462 (0.781–2.605) 4 5.3 (4.2–16.1) 13.8 (11.2–22.1) 0.693 (0.313–1.045) 0.063 0.565 0.048
30–39  137 18.9 (6.2–24.2) 12.7 (6.8–24.7) 1.268 (0.589–2.310) 3 1.6 (0.8–2.2) 11.0 (6.2–16.3) 0.132 (0.082–0.138) 0.008 0.494 0.004
≥40 22  2.4 (1.7–6.2) 2.9 (0.9–13.4) 1.067 (0.680–1.821) 11 2.5 (1.4–8.0) 13.5 (6.9–20.9) 0.191 (0.123–0.740) 0.925 0.026 0.001
Total  337 20.0 (8.3–30.3) 15.5 (7.3–30.4) 1.342 (0.683–2.509) 18 2.8 (1.5–6.3) 13.3 (6.7–21.2) 0.191 (0.127–0.778) 2.1.E-05 0.487 1.6.E-07
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 values were determined by a non-parametric Mann–Whitney U-test between con
igniﬁcant level at 0.05 that is underlined.
able 1. In the population of healthy Korean males examined in
his study, the overall concentrations of testosterone appeared to
e slightly higher than those of epitestosterone (P = 0.026); how-
ver, the urinary ranges of the 25/75th percentiles showed similar
xcretion rates of testosterone and epitestosterone across all ages,
hich suggests that normal men  have similar urinary levels of
estosterone and epitestosterone (Table 2). In the frequency dis-
ributions of urinary T/E values, a mean T/E ratio of less than 2.0
as observed in 67.1% of all subjects (<1.0: 38.3%; <2.0: 28.8%),
eing between 0.15 and 5.46 within the 99% percentile cut-off
able 3
omparison of urinary concentrations and ratio of testosterone (T) and epitestosterone (E
emoving the outliers.
Age (yr.) Control subjects Marijuana
n T (ng/mL) E (ng/mL) T/E ratio n T (ng
20–29 157 21.0 (16.9–29.0) 16.0 (8.6–30.2) 1.344 (0.688–2.551) 4 5.3 (4
30–39  132 18.6 (6.1–23.5) 12.3 (6.6–23.6) 1.254 (0.507–2.247) 3 1.6 (0
≥  40 21 2.5 (1.8–6.3) 2.9 (1.0–14.4) 0.977 (0.658–1.688) 11 2.5 (1
Total  310 19.5 (7.5–27.7) 13.6 (7.1–27.7) 1.287 (0.621–2.431) 17 2.8 (1
esults are medians with the 25th and 75th percentiles as interquartile range in parenthe
 values were determined by a non-parametric Mann–Whitney U-test between control s
igniﬁcant level at 0.05 that is underlined.ses.
ubjects and marijuana users according to their normality results, and were set the
level. Among the 337 male subjects, one had a urinary T/E ratio
>6, which could be considered as the unusual metabolic ratio
(Fig. 1B). Therefore, this one outlier that exceeded the upper fence
1.5 (IQR) from the third quartile was  removed from the dataset
using the deﬁnition provided by John Tukey [26]. To ensure a reli-
able comparison between the marijuana user and control groups,
27 suspected outliers for testosterone were removed from the
distributed datasets in the population of 337 drug-free males,
and one outlier was  removed from among the marijuana users
(Table 3).
) between control subjects and marijuana users in a Korean male population after
 users P-value
/mL) E (ng/mL) T/E ratio T E T/E
.2–16.1) 13.8 (11.2–22.1) 0.693 (0.313–1.045) 0.099 0.745 0.062
.8–2.2) 11.0 (6.2–16.3) 0.132 (0.082–0.138) 0.002 0.575 0.001
.4–8.0) 13.5 (6.9–20.9) 0.191 (0.123–0.740) 0.492 0.079 0.001
.5–6.0) 13.0 (6.5–20.3) 0.191 (0.125–0.665) 4.8.E-06 0.461 2.6.E-07
ses.
ubjects and marijuana users according to their normality results, and were set the
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.2. Effects of marijuana use on urinary levels of testosterone and
he T/E ratio
The urinary levels of two androgens in the control subjects were
ompared with those of 18 marijuana abusers who tested cannabis-
ositive (≥15 ng/mL THC–COOH) [27]. In the marijuana users,
he urinary concentrations of testosterone and epitestosterone
ere ≥70 ng/mL, and the median concentration of testosterone
as approximately four times lower than that of epitestosterone
Table 2). The median testosterone level was 2.82 ng/mL, with the
ndividual values ranging from 0.04 to 65.0 ng/mL (which included
ne outlier with a very high value) (data not shown). Although the
estosterone value for one of the 18 marijuana users, which showed
 large variation, was excluded from the analysis, the overall con-
entrations of testosterone appeared to be remarkably lower than
hose of epitestosterone (P < 0.003). The urinary concentrations of
he two androgens and T/E ratio according to age-matched distri-
ution were compared to provide an overview of the differences in
heir levels between marijuana users and control subjects (Table 3).
or the comparison, age was categorized as follows: 20 to 29, 30 to
9, and ≥40 years. The age-matched and total differences between
arijuana users (n = 17) and non-users (n = 310) were evaluated
sing a non-parametric Mann–Whitney U test.
Compared to the control group, the overall median concen-
ration of testosterone in marijuana abusers was observed to be
onsiderably (more than 6-fold) lower (P < 0.000005). For age-
atched comparisons, however, the P values were statistically
igniﬁcant in only for subjects in their thirties, with decreased
estosterone levels in marijuana group. No signiﬁcant difference
as found between the two groups for the other age categories,
hich may  be due to the wide variation in individual responses
o marijuana abuse. As a consequence, there was no correlation
etween the urinary testosterone concentrations and age-matched
arijuana-smoking male users, as was also found for epitestos-
erone. The median values of the T/E ratio in the marijuana user
nd non-user groups were 0.191 and 1.287, respectively. Further-
ore, the T/E ratio in all age categories was signiﬁcantly lower in
he marijuana group, regardless of whether outliers were removed
r not (Tables 2 and 3). However, even though the T/E ratio dif-
ered markedly between the two groups, it was found that urinary
estosterone levels in the marijuana users showed an overlap with
he low values measured in the control group.
. Discussion
In contrast to the information available relating to reference
anges for the urinary steroid proﬁle in Caucasian and Latin-
merican populations [28,29], there has been only limited data that
nclude reference ranges for a small number of subjects in a Korean
opulation to date [23,24,30]. Because racial difference is one of the
arameters associated with differences in steroid metabolism and
ndrogen-dependent pathologies, reference values obtained from
 healthy Korean population are necessary [29,31]. Accordingly, in
he present study, reference values for testosterone and epitestos-
erone, as well as the corresponding T/E ratio, were determined
rom a large Korean male population, thereby allowing the deter-
ination of abnormal values as an indicative tool for evaluating
he abnormal steroid metabolism caused by marijuana. In control
roups, testosterone levels tend to start declining at 40 years after
aturation (Tables 2 and 3), which may  be due to andropause,
hich is characterized by an age-related gradual and progressive
ecline in testosterone levels to below the normal range found in
oung men  [32].
In general, the urinary excretion of epitestosterone in males is
nown to be nearly constant until the sixth decade of life [14,15].& Molecular Biology 140 (2014) 100– 105 103
In the present study, however, levels of epitestosterone in Korean
men  started to show a slight decline at age of 40 years and above
(Tables 2 and 3). In addition, our results showed that there were
no signiﬁcant differences in the mean T/E ratio across all age cate-
gories, which is consistent with previous ﬁndings in adults [12].
Recently, the genetic variability of urinary T/E ratios has been
reported [18,23]. Compared with previous reports [28,29,31], the
lower androgen levels in Korean males than in Caucasian males may
be explained by the fact that the pattern of testosterone excretion
has been shown to be strongly correlated with a UGT2B17 (uri-
dine diphosphoglucuronosyl transferase) deletion polymorphism,
which is up-regulated in del/del genotype of Korean [23]. In addi-
tion, the distribution of T/E ratio values showed that the values
were mostly less than 1, which may  be due to the lower con-
centrations of testosterone glucuronide, which has been shown
to be a characteristic of Asians [33]. To our knowledge, this is
the ﬁrst study to determine the reference values of testosterone
and epitestosterone, and the corresponding T/E ratios, in a large
healthy Korean male population, and we  have shown that these
values are useful for comparison with the respective estimated
values.
Studies have shown that marijuana and its active component,
THC, may  have an impact on multiple endocrine systems, including
gonadal, adrenal, prolactin, growth hormone, and thyroid hor-
mone systems [3–5]. In particular, a suppressive effect has been
observed on the gonadal steroids as reproductive hormones, along
with activation of the hypothalamic–pituitary–adrenal (HPA) axis.
The effects of cannabis on male sexual and reproductive function
in animals results in a signiﬁcant decrease in both testosterone
and gonadotropin [6–8]. Although the effect of chronic exposure
is less dramatic than that of acute treatment [8], both acute and
chronic THC administration in animals appears to cause a sig-
niﬁcant depression of testosterone release and gonadal function
[3,4].
In contrast to the animal models, the effects of marijuana
in humans have not been conclusively elucidated [9,10]. Some
studies have reported no effects on circulating testosterone, LH,
or FSH levels in chronic marijuana users [10,11], whereas oth-
ers have demonstrated that cannabis negatively affects male
reproductive physiology, suggesting that chronic marijuana use
could reduce the levels of circulating testosterone, FSH, and LH
levels compared with those in controls who had never used
marijuana [9,34]. It has been suggested that reduced testos-
terone synthesis may  be the result of the following THC effects:
(1) the direct inhibition of androgen release from Leydig cells;
(2) down-regulation of gonadotropin/luteinizing hormone (LH)
or follicle-stimulating hormone (FSH) release from the anterior
pituitary through a decrease in gonadotropin-releasing hormone
(GnRH); or (3) down-regulation of cannabinoid (CB1) receptor
expression in the hypothalamus or testes [3–6,11]. These discrep-
ancies among human studies may  be due to differences in study
design, but may  also reﬂect the development of tolerance [3,5], and
it is difﬁcult to evaluate the endocrine effects of marijuana using
only the extent of down-regulated urinary testosterone levels, as
suggested by other previous studies.
In this study, the marijuana use in Korean males was  shown to
inhibit urinary excretion of testosterone; however, decreased levels
of testosterone in the two investigated groups were detected only
in participants in their thirties, showing no effects in the other age-
matched subjects (Table 2). Therefore, estimates of testosterone
excretion are of limited value for detecting cannabis misuse, which
may be due to the large variation between individuals caused by
differences in ethnicity, smoking habits, and body composition
[20,35]. Thus, it is important to evaluate androgen action by under-
taking carefully designed studies that correct for parameters of
additional inﬂuence, which could result in useful and fascinating
104 J.-Y. Moon et al. / Journal of Steroid Biochemistry 
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(2006) 687–693.ere 0.191 and 1.287 in the marijuana user and non-user groups, respectively, and
he difference was  found to be signiﬁcant (P < 1.6 × 10–7).
nformation regarding the association between marijuana abuse
nd testosterone levels.
Interestingly, the urinary T/E ratio, although not the testos-
erone level, indicates the existence of a relationship between
arijuana use and depression of male gonadal steroids, regard-
ess of age. There are however, certain limitations to the present
tudy, notably the small number of marijuana smokers investi-
ated (only 18 males), which could limit the statistical power to
etect weak associations and effects related to marijuana use. How-
ver, even with this limitation, we suggest that the urinary T/E
atio may  prove to be a better indicator for evaluation of metabolic
hanges in gonadal functions caused by marijuana abuse in Korean
ales (Fig. 2). In addition, the correlation between T/E levels and
he THC–COOH concentrations in both drug-free control and mar-
juana user groups were evaluated (Supplementary Table 1). The
oncentrations of testosterone and epitestosterone are negatively
orrelated with the age in control group, while no variables are cor-
elated in marijuana users. Further studies are required to conﬁrm
he possible associations between exposure to marijuana and the
ndocrine system in hormonal regulation among Korean popula-
ions, as well as in Caucasian populations.
Although the creatinine correction could be often inﬂuenced by
ime of day, age, sex, race/ethnicity, diet, body mass, and activity
evel, our results might not be convinced of the results regarding
he individual concentrations of testosterone and epitestosterone
ithout consideration for dilution of urine samples.
. Conclusions
For the ﬁrst time, reference values for urinary testosterone
nd epitestosterone levels, which can calculate the T/E ratio, in a
arge Korean male population, which may  allow the evaluation of
bnormal steroid metabolism, have been investigated. An associa-
ion between marijuana smoking and urinary androgen levels was
etected; however, this appeared to be an age-speciﬁc effect. In
ddition, the habitual marijuana smokers have lower T/E ratios, a
nding that supports the hypothesis of depression of male gonadal
teroids after cannabis use. It can be speculated that the T/E ratio
ather than testosterone levels could be used as a potential param-
ter for indicating the suppression of male gonadal function after
moking marijuana.
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